progress against lymphoma. 1970–1979 progress against lymphoma 1970–1979 1974: fda approves...
TRANSCRIPT
Progress Against
Lymphoma
Progress Against Lymphoma
1970–1979
Progress Against Lymphoma
1970–19791974: FDA approves doxorubicin, a vital part of combination chemotherapy
Progress Against Lymphoma
1970–19791975: New chemotherapy regimen boosts Hodgkin lymphoma cure rates to 70 percent
1975: Era of bone marrow transplantation begins – extending lives of many patients with leukemia and lymphoma
Progress Against Lymphoma
1970–19791976: CHOP regimen boosts cure rates for non-Hodgkin lymphoma
Progress Against Lymphoma
1980–1989
Progress Against Lymphoma
1980–19891980: Imaging tests begin replacing surgery for Hodgkin lymphoma staging
Progress Against Lymphoma
1980–1989Late 1980s: Benzene established to cause blood cancers
Progress Against Lymphoma
1990–1999
Progress Against Lymphoma
1990–19991993: Mantle cell lymphoma recognized as a subtype of non-Hodgkin lymphoma
Progress Against Lymphoma
1990–19991990s: Research suggests a therapeutic vaccine for follicular lymphoma could be possible
1995: Lymphocyte transfusions re-induce leukemia remissions
1995: Bone marrow transplantation improves survival for relapsed non-Hodgkin lymphoma
Progress Against Lymphoma
1990–19991997: FDA approves first-ever targeted cancer drug, rituximab
1997: Classification system established for non-Hodgkin lymphoma
Progress Against Lymphoma
1990–19991998: New technique enables older patients to undergo life-saving stem cell transplants
Progress Against Lymphoma
2000–Present
Progress Against Lymphoma
2000–Present2001: Scientists discover that common type of lymphoma is two distinct diseases
Progress Against Lymphoma
2000–Present2002: Adding rituximab to ''CHOP'' chemotherapy boosts survival
2002: Radioimmunotherapy introduced to treat lymphoma
Progress Against Lymphoma
2000–Present2005: Bortezomib shrinks tumors in mantle cell lymphoma
Progress Against Lymphoma
2000–Present2007: PET scanning helps guide lymphoma treatment
Progress Against Lymphoma
2000–Present2008: First drug approved specifically for T-cell lymphoma treatment
Progress Against Lymphoma
Five-Year Survival
42
47
52
57
62
67
72
1975
1977
1979
1981
1983
1985
1987
1989
1991
1993
1995
1997
1999
2001
2003
2005
2007
2009
Year of Diagnosis
% o
f Pa
tien
ts S
urv
ivin
g F
ive
Ye
ars
Source: National Cancer Institute
Progress Against Lymphoma
Mortality
4
5
6
7
8
9
10
11
12
1970
1972
1974
1976
1978
1980
1982
1984
1986
1988
1990
1992
1994
1996
1998
2000
2002
2004
2006
2008
2010
Year of Death
Ca
nce
r D
ea
ths
pe
r 1
00
,00
0 P
eo
ple
Source: National Cancer Institute
Progress Against Lymphoma
New Cases
11
13
15
17
19
21
23
25
27
1973
1975
1977
1979
1981
1983
1985
1987
1989
1991
1993
1995
1997
1999
2001
2003
2005
2007
2009
Year of Diagnosis
Ne
w C
an
cer
Ca
ses
pe
r 1
00
,00
0 P
eo
ple
Source: National Cancer Institute
Visit CancerProgress.Net for an interactive timeline of progress against a range of common cancers
CancerProgress.Net is a project of the American Society of Clinical Oncology, which represents nearly 30,000 physicians who treat people with cancer and
research new cures